RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia

RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemiaLeukemia, Published online: 3 October 2017; doi:10.1038/leu.2017.303

Source: Leukemia - October 3, 2017 Category: Hematology Authors: I S Jerchel A Q Hoogkamer I M Ari ës E M P Steeghs J M Boer N J M Besselink A Boeree C van de Ven H A de Groot-Kruseman V de Haas M A Horstmann G Escherich C M Zwaan E Cuppen M J Koudijs R Pieters M L den Boer Source Type: research